NCT05307731View on ClinicalTrials.gov

Fingolimod for Type 2 Diabetes Mellitus

PHASE4RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 15, 2022

Primary Completion Date

March 15, 2026

Study Completion Date

March 15, 2026

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Fingolimod

0.5mg daily for 90-180 days, in addition to guideline-based treatment for DM

DRUG

guideline-based treatment for DM

guideline-based treatment for DM

Trial Locations (1)

110016

RECRUITING

Department of Neurology, General Hospital of Northern Theater Command, Shenyang

All Listed Sponsors
lead

General Hospital of Shenyang Military Region

OTHER